The Global Health Network is hosting regular online interactive workshops to facilitate learning and discussion around the important research questions that are arising during the COVID-19 pandemic 

In each of these open workshops, we will bring together an expert panel of researchers from around the globe to share their research efforts towards tackling the pandemic, and to discuss the research priorities that future COVID-19 trials and studies will need to address. Each workshop will close with an interactive 'Question and Answer' session to allow participants to put forward their own questions, identify relevant resources and gather consensus with the panel and other attendees. We are hosting workshops in multiple languages and have so far supported sessions led in English, Portuguese, Spanish and French. 

Our upcoming workshops, and details of how to register for them, are listed below. Here you can also find recordings and reports from each of our previous workshops

Would you like to see a particular area of COVID-19 research discussed in one of these workshops? Do you have a particular research question that needs to be addressed? Would you or your organisation like our support in organising a similar COVID-19 research workshop? If so then please don't hesitate to get in touch and get involved!

*This area is being continually updated so please check back here for new workshops that could help your research team with your COVID-19 study.*

 

Upcoming Workshops

***

Evaluating the Global Impact of COVID-19 on Child Health and Births

Tuesday 21 September, 1 PM BST (London, UK)

In 2018 at least 5.3 million children under 5 years died globally of preventable conditions which include. While gains have been made over the years to improve access to New-born and Child health services in low-and- middle income countries, some gaps still exist.

Several months ago, the world experienced a new respiratory infection caused by SARS-CoV2 (COVID-19). The COVID-19 pandemic has challenged people’s health and well-being in both developing and developed countries. Global assessments of health systems have shown that there are challenges to provide essential health services and reduced demand for and access to health services. Disruptions in essential health services and modification of health seeking behaviours is likely to substantially modify child morbidities and mortalities trends, particularly in low-middle income settings. Unprecedented reductions in preterm birth rates (up to 90% in Denmark) and very low birth weight (70% in Ireland) have been reported during lockdowns in some countries while in others like Nepal show an opposite trend, and increases in stillbirth.

It is therefore imperative that the global community assesses the impact of COVID-19 on new born and child health using high quality data, and to understand the underlying cause(s) to ensure that the hard-won gains from many years of investments are not eroded in the short term.

Talk 1 - Studying Perinatal Health Internationally during the COVID-19 Pandemic: The iPOP Study.
Talk 2- Repercussions of social isolation due to Covid19 on Neonatal ICU child patients.

           

 *** 

COVID-19 vaccination in low and middle-income countries: lessons from past and current campaigns

Wednesday 22 September, 1 PM BST (London, UK)

This webinar is an opportunity to share experiences and learnings from past vaccination campaigns during epidemics, as well as early lessons from the COVID-19 rollout in low and middle-income countries. We will discuss the barriers and enablers currently being experienced by vaccination teams as they roll out COVID-19 vaccines, and the development of local solutions. This is the third event of a UK Public Health Rapid Support Team (UK-PHRST) discussion series on outbreak preparedness and response which aims to encourage reflection and shared learning, as well as creative discourse.

Learning Objectives:

• To provide an opportunity for the sharing of experiences of COVID-19 vaccination in low and middle-income countries.

• To encourage the sharing of barriers, enablers, lessons and local solutions from past and current epidemic/pandemic vaccination campaigns that can support the COVID-19 vaccine rollout in low and middle-income countries.

Chair: Professor Beate Kampmann Professor of Paediatric Infection & Immunity Director, The Vaccine Centre, London School of Hygiene and Tropical Medicine

Speakers: Ms Julie Collins Research Fellow in Public Health, UK Public Health Rapid Support Team London School of Hygiene & Tropical Medicine and Public Health England, United Kingdom

Dr Mohammed Abdulaziz Head, Division of Disease Control and Prevention, Africa Centres for Disease Control and Prevention

Ms Chioma Dan-Nwafor Epidemiologist, Nigeria Centre for Disease Control /Africa Centres for Disease Control and Prevention

Visit: https://uk-phrst.tghn.org/

Visit: https://www.lshtm.ac.uk/research/centres/vaccine-centre

     

  *** 


Previous Workshops - Recordings and Reports

 


View this webinar in full screen

Neurological Associations of COVID-19: Cerebral venous sinus thrombosis associated with SARS-CoV-2

08/09/21

The COVID-19 pandemic, caused by SARS-CoV-2, is of a scale not seen since the 1918 influenza pandemic. Although the predominant clinical presentation is with respiratory disease, neurological manifestations are frequent. In this episode, we will hear about the cerebral venous sinus thrombosis associated with SARS-CoV-2 itself and the vaccine against SARS-CoV-2. We will also have a brief literature digest from @Neuropsychcovid.


View this webinar in full screen

How to navigate practical research challenges during the COVID-19 pandemic: The African Story

31/08/21 

It has been almost two years since the outbreak of the SARS-COV-2 Viral pandemic. Part of the response to this pandemic has been research to inform policy and management options. Needless to say, conducting research during epidemics is riddled with several coordination and implementation challenges, and several African institutions have rich experiences that we can glean and learn from.

To this effect, The Global Health Network in partnership with the Uganda Virus Research Institute organised this webinar, bringing together experts in the field from across Africa to share their experiences and unique challenges of conducting research during outbreaks and how they navigated them to deliver high quality research. 

View the presentations from this webinar from Dr Jane Achan [PDF, 0.9MB], Dr Sylvie Kwedi Nolna [PDF, 0.9MB] and Dr Jennifer Serwanga [PDF, 0.1MB]


View this webinar in full screen

Neurological Associations of COVID-19: Neurological Covid. From Single Cells to Special Centres!

21/07/21

The COVID-19 pandemic, caused by SARS-CoV-2, is of a scale not seen since the 1918 influenza pandemic. Although the predominant clinical presentation is with respiratory disease, neurological manifestations are frequent. In this episode, we will hear about the neuroimmune responses during COVID-19 and the latest research on neuro COVID from India. We will also have a brief literature digest from @Neuropsychcovid

 


View this webinar in full screen

Platforms & registries for sharing participant-level clinical-epidemiological, OMICs & imaging data

14/07/21

In the research and public health response to COVID-19, there has been a rush to share data, marked by an explosion of population- and discipline-specific registries. Data sharing platforms, which generally predate the COVID-19 pandemic, have been expanded to include different types of COVID-19-related data. In this webinar, we present a comprehensive, living overview of COVID-19-related platforms and registries for sharing participant-level clinical-epidemiological, OMICs, and imaging data and review the interoperability of data sharing efforts and how these initiatives map to best practice for ethical, equitable, and effective data sharing and application of the FAIR Principles for managing data resources.

Access the database of data sharing platforms | Read the webinar report


Click here to view this webinar in full screen. 

Epidemic Ethics: Governing Global Health in Pandemics: Evolution and Lessons Learned

21/06/21

The following questions formed the basis of the seminar’s panel discussion. Seminar attendees were invited to submit questions in advance of the seminar when they registered or during the live discussion.

1) Where has global health governance succeeded in the COVID-19 pandemic?

2) Where has it failed?

3) What are the key ethical lessons we’ve learned in how to govern the response to a global pandemic?


Click here to view this webinar in full screen. 

Epidemic Ethics: Challenges & ethical implications of distinguishing between research & rollout in pandemic responses

24/05/21

The scale and pace of health research in the COVID-19 pandemic has resulted in an exceptionally rapidly evolving evidence base, with governments and public health authorities rolling out strategies for COVID-19 diagnosis, treatment and prevention at an unprecedented rate. In such circumstances, it can be challenging to distinguish between research and public health, particularly when the interventions being researched may also be implemented in evolving public health responses. This seminar looks at the moral grounds for drawing distinctions between research activities and public health practices in a pandemic, and the implications of such distinctions for how they are conducted, governed, and communicated about with relevant populations.


Click here to view this webinar in full screen. 

Neurological Associations of COVID-19: Thrombotic events following vaccination

18/05/21

The COVID-19 pandemic, caused by SARS-CoV-2, is of a scale not seen since the 1918 influenza pandemic. Although the predominant clinical presentation is with respiratory disease, neurological manifestations are frequent. In this episode, we will discuss thrombotic events following COVID-19 vaccination. We will also have a brief literature digest from @Neuropsychcovid.


Click here to view this webinar in full screen. 

Epidemic Ethics: Adapting Ethics Review During the COVID-19 Pandemic

10/05/21

It is of critical importance to conduct research during public health emergencies, such as the COVID-19 pandemic. Yet, research and the ethical review of research in these contexts present unique challenges, including the rapidity with which research and ethical review must occur. This seminar will explore the unique challenges associated with the ethical review of research during the COVID-19 pandemic, highlight the manner in which ethical review has adapted to address these challenges over the past year, and identify future opportunities for ethical review of research during public health emergencies.


Click here to view this webinar in full screen. 

Epidemic Ethics: Ethical considerations in alternative COVID-19 vaccination strategies

26/04/21

Faced with scarce and uncertain COVID-19 vaccine supplies, many countries are considering adopting vaccination schedules that differ from the recommendations of vaccine manufacturers. Some have extended the interval between doses for two-dose vaccines to provide at least some protection for a larger number of people sooner. Others are looking at maximizing the number of people receiving some degree of protection by administering partial doses or foregoing the second dose of two-dose vaccines altogether. A third approach under consideration is whether two different COVID-19 vaccines could be given at the same time, to complete a two-dose vaccination regimen in one visit. Deviations from manufacturer's recommendations could be seen as experimental, and have the capacity to threaten public confidence, but they might also avert substantial morbidity and mortality in populations. This seminar will explore the ethical considerations that ought to guide decision-making regarding adopting alternative vaccination strategies or implementing vaccine manufacturer recommendations.


Click here to view this webinar in full screen. 

Neurological Associations of COVID-19: How does SARS-CoV-2 affect the brain in mild and severe disease?

20/04/21

The COVID-19 pandemic, caused by SARS-CoV-2, is of a scale not seen since the 1918 influenza pandemic. Although the predominant clinical presentation is with respiratory disease, neurological manifestations are frequent. In this episode, Dr Clarissa Lin Yasuda will talk about how SARS-CoV-2 impairs neuronal viability and Prof Paul Harrison will talk about his research on bidirectional associations between COVID-19 and psychiatric disorder published in Lancet Psychiatry. We will also have a brief literature digest from @Neuropsychcovid.


Click here to view this webinar in full screen. 

Epidemic Ethics: Vaccine diplomacy during the COVID-19 pandemic

12/04/21

COVID-19 vaccines are one of the most important resources on the planet. Consequently, how these precious resources are used and shared (or not) has the capacity to significantly impact relationships between countries. Indeed, COVID-19 vaccines can and have been used and shared (or not) as a means of building or managing international relations. As a result, some have argued that vaccine production capacity and/or excess vaccine supply can position countries as diplomatic and moral powerhouses. Given commitments and efforts to distribute COVID-19 vaccines fairly, vaccine diplomacy warrants ethical scrutiny to ensure it helps to further this aim. This seminar explores the ethics of vaccine diplomacy during the COVID-19 pandemic.


Click here to view this webinar in full screen. 

Disease outbreak preparedness and response: education experiences and ideas

01/04/2021

This is the first of a discussion series on outbreak preparedness and response to encourage sharing of experiences and reflections that further our understanding of how we can best support learning in these contexts. It will include presentations on educational programmes developed in response to disease outbreaks.


Click here to view this webinar in full screen. 

Epidemics Ethics: A grand experiment: ethical responsibilities in the global rollout of COVID-19 vaccines

29/03/2021

The unprecedented speed and scale of global rollouts of COVID-19 vaccines is playing a critical role in effectively responding to the pandemic. Decisions about global vaccine rollout have been made rapidly, informed by best available clinical research findings. What ethical responsibilities arise to monitor the safety and effectiveness of pandemic vaccines which are rolled out while still being evaluated in clinical trials? Globally, as over eight million doses of COVID-19 vaccines are received per day, what mechanisms should exist to ensure the sustained capacity to monitor and evaluate the outcomes of vaccination?


Click here to view this webinar in full screen. 

Neurological Associations of COVID-19: COVID and the brain in Britain and Brasil

16/03/2021

The COVID-19 pandemic, caused by SARS-CoV-2, is of a scale not seen since the 1918 influenza pandemic. Although the predominant clinical presentation is with respiratory disease, neurological manifestations are frequent. In this episode, Dr Lúcia Brito will discuss mechanisms of brain disease in COVID-19 and Dr Ben Michael will talk about spectrum, risk factors, and outcomes of neurological and psychiatric complications of COVID-19. The webinar is followed by the WHO COVID-Neuro Clinical Exchange which in this first session will involve an interactive case-based discussion.

Find out more about the COVID-19 Neuro Network


Click here to view this webinar in full screen. 

Epidemics Ethics: Mandates and special privileges for COVID-19 vaccination

15/03/2021

With COVID-19 vaccination underway or on the horizon in many countries, many are turning their attention to whether the vaccination should be made mandatory, and if so, under what conditions, for whom, and in what contexts. This webinar will explore the ethics of mandatory COVID-19 vaccination both in general and in particular settings (e.g., health care settings), as well as examine the ethics of affording special privileges to those who are vaccinated, e.g., to travel and to gather in large groups.



Click here to view this seminar in full screen.

Equitably Harnessing the Power of Health Data: Time for Action and Collaboration

01/03/2021

The COVID-19 pandemic has highlighted the critical importance of generating rigorous evidence for decision-making. To bring equity, the global health research community needs to find ways to unite and generate actionable insights from data. This interactive session will explore how collaborations and strategic partnerships can harness the power of data to tackle the most devastating health issues. We will draw on the experience of The Global Health Network and the International COVID-19 Data Alliance, convened by Health Data Research UK, and several speakers from around the world.

Find out more here

 


Ethics Review in Pakistan During COVID-19: A situational analysis

23/02/2021

The present COVID-19 pandemic as well as past public health emergencies (PHEs) affecting Pakistan (e.g. the 2005 Kashmir earthquake, the 2010 floods) have demonstrated the need for ethics committees (IRBs) to be able to review proposals for health interventions urgently and with competence to relieve the health effects of the PHE while also maintaining normal operations.

This workshop is carried out to respond to the need to analyse the preparedness and response of ethics committees (ethical review framework and process) in Pakistan for conducting ethics review of COVID-19 research and to better prepare for, and respond to, future PHEs.


Neurological Associations of COVID-19: Olfactory transmucosal invasion and psychosis risk

17/02/2021

The COVID-19 pandemic, caused by SARS-CoV-2, is of a scale not seen since the 1918 influenza pandemic. Although the predominant clinical presentation is with respiratory disease, neurological manifestations frequent. In this episode, we will present latest data on olfactory transmucosal SARS-CoV-2 invasion, and discuss COVID-19 and psychosis risk.

The COVID-Neuro Clinical Exchange is co-organized by the Global Health Network and World Health Organization (WHO) Neurology & COVID-19 Global Forum. Our goals are to promote discussion around neurological care and COVID-19 in all settings and the first session will involve an interactive case-based discussion.

Find out more about the COVID-19 Neuro Network



Click here to view this seminar in full screen.

Neurological Associations of COVID-19: A Russian perspective and data from the ALBACOVID

12/01/2021

The COVID-19 pandemic, caused by SARS-CoV-2, is of a scale not seen since the 1918 influenza pandemic. Although the predominant clinical presentation is with respiratory disease, neurological manifestations frequent. In this episode, we will present data from a retrospective, observational study from hospitalised patients in Spain and a Russian perspective on COVID-neuro. We will also have a brief literature digest from @Neuropsychcovid and an introduction by the WHO Clinical Exchange Network.

Find out more about the COVID-19 Neuro Network



Click here to view this seminar in full screen.

Epidemics Ethics: Effective COVID-19 vaccine(s)?

14/12/2020

The development of a safe and effective COVID-19 vaccine will represent a significant triumph. Yet, perhaps counter-intuitively, this could raise rather complex ethical questions and challenges for other COVID-19 vaccine clinical trials. For instance, if a vaccine were to be authorized for emergency use, would it be unethical for vaccine trials to continue to employ placebo control arms? If not, should trial participants be discouraged from withdrawing from trials and accessing authorized vaccines? What methodological approaches should be used to generate evidence on COVID-19 vaccines after interim results for vaccines are available and vaccines are authorized or approved for use outside of clinical trials? This seminar will explore the ethical implications of promising COVID-19 vaccine candidates for vaccine research in 2021.

 



Click here to view this seminar in full screen.

Covid Neuro Network: Pooling global data on NeuroCOVID

11/12/2020

The COVID-19 pandemic, caused by SARS-CoV-2, is of a scale not seen since the 1918 influenza pandemic. Although the predominant clinical presentation is with respiratory disease, neurological manifestations frequent. In this episode, it is all about pooling global data on NeuroCOVID. Leads of the European Academy of Neurology (EAN) Neurocovid Registry and the Global Consortium Study (GCS) of Neurological Dysfunction in COVID-19 will present their registries. We will also present first data from the COVID-Neuro Network’s global meta-analysis of individual patient data on neurological associations of COVID-19. We will also have a brief literature digest from @Neuropsychcovid.

 



Click here to view this seminar in full screen.

Virtual Biorepository resources for COVID 19 and other diseases of epidemic potential

10/12/2020

The COVID 19 pandemic has highlighted our interconnectivity and the need for stakeholders to address gaps and challenges together in a broader, participatory forum. One of the recurring challenges has been the lack of accessible, quality samples to advance the science of high impact pathogens like the newly emerged coronavirus. Trusted, well-archived and well-characterized samples, and readily accessible resources are needed to avert delays in development of treatments, vaccines, and diagnostic tests.

 



Click here to view this seminar in full screen.

PHEPREN: Ethics of research in pregnancy

30/11/2020

Recent evidence suggests that pregnant women are at a higher risk of morbidity and mortality from COVID-19, compared with age-matched women who are not pregnant. Yet the historical and systematic exclusion of pregnant women from research continues in the context of the COVID-19 pandemic, resulting in a lack of evidence for this population. How can pregnant women be ethically and safely included in research and what part should researchers play in this? What role is there for community engagement to reconcile cultural norms and beliefs with the ethical and clinical rationale for research during pregnancy? And how do current governance mechanisms and regulation help or hinder the inclusion of pregnant women in research?

 



Click here to view this seminar in full screen.

Covid 19 and stroke: What are the pressing concerns?

25/11/2020

This is a webinar led by Members of the WHO'S NeuroCOVID Forum (Dr Alessandro Padovani and Dr Lucia Brito) and Fiocruz (Dr Cristiane Bresani) to discuss the challenges and ideas to investigate cerebrovascular manifestations potentially related to COVID-19. The panellists will share their experience in the field, which includes a multicentre case-control study on the association between stroke and SARS-CoV-2 infection, run by Fiocruz in Brazil. This event will be a forum open to all who are interested in clinical research, neurology and COVID-19.

 



Click here to view this seminar in full screen.

PHEPREN & GFBR: Ethics of adaptive trial designs

16/11/2020

The urgency of the COVID-19 pandemic has necessitated the investigation of multiple potential therapies in a timely way. In this context, adaptive trials are taking place to investigate multiple treatments and that are intended to continue beyond the evaluation of any one treatment. These complex trials have the potential to answer more questions efficiently and improve care for research participants by dropping therapies that are shown to be ineffective, but they present challenges. How should the risks and benefits be communicated to participants, understanding that the benefit:harm ratio may change over the course of the study? What consent model is appropriate for such dynamic trials? And how can regulators and research ethics committees be supported to understand and evaluate these statistically and logistically complex trials?

 



Click here to view this seminar in full screen.

COVID Neuro Network: Neuro COVID-19 in India and encephalitis lethargica

5/11/2020

The COVID-19 pandemic, caused by SARS-CoV-2, is of a scale not seen since the 1918 influenza pandemic. Although the predominant clinical presentation is with respiratory disease, neurological manifestations are frequent. In this episode, we will discuss COVID-neuro cases from India and encephalitis cases from the UK. We will also have a brief literature digest from @Neuropsychcovid.

 



Click here to view this seminar in full screen.

PHEPREN & GFBR: Ethics of data sharing in health research

2/11/2020

Data sharing has the potential to increase scientific efficiency by maximising the availability and utility of data, and can be critical to generating knowledge during a public health emergency. But how can we share for maximum benefit and least harm, and without exacerbating existing inequalities between researchers from well-resourced and low-resourced settings? What do we need to do to ensure that data sharing policies and processes are respectful of participants and communities and what governance mechanisms need to be in place before patient data can be shared and used in health research?

 



Click here to view this seminar in full screen.

Research In Focus: Ensuring Global Access to Surgery During COVID-19

13/10/0220

The Lancet Commission on Global Surgery in 2015 found that Treatment for surgical conditions, a broad range of diseases that represent approximately 30% of the global burden of disease and span 100% of disease sub-categories, remains out of reach for the majority of the world’s population. This results in loss of life and reduced welfare for millions of people, and stunts economic development. In this session, hear from Prof. Kokila Lakhoo on the vital global efforts to ensure access to surgery and from Dr Anita Makins on the impact COVID-19 is having on women’s health.

 



Click here to view this seminar in full screen.

Neurological Associations of COVID-19: Study results from COPING and CoCo-Neuro

27/10/2020

The COVID-19 pandemic, caused by SARS-CoV-2, is of a scale not seen since the 1918 influenza pandemic. Although the predominant clinical presentation is with respiratory disease, neurological manifestations frequent. In this episode, we will present results from two studies from the UK and France. The COPING study assesses the impact of the novel coronavirus (COVID-19) pandemic on mental and neurological health, and how different factors associated with the virus are affecting the population. The CoCo-Neuro study characterises the neurological and psychiatric manifestations occurring in the context of Covid-19 infection and aims to improve clinical management, rehabilitation and follow-up.

 



Click here to view this seminar in full screen.

Epidemics Ethics: COVID-19 vaccination in an era of vaccine hesitancy

5/10/2020

In 2019, WHO named vaccine hesitancy one of the ten greatest threats to global health. Now, in the midst of the COVID-19 pandemic, when many are pinning their hopes for a return to normalcy on an effective vaccine, understanding vaccine hesitancy takes on greater urgency and complexity. In a public bombarded by misinformation, subjected to unprecedented restrictions in the name of public health, affected by increasingly polarised/politicised debate, will COVID-19 vaccine programs gain the acceptance and trust needed to be successful? (And what will happen if they don't?)

 



Click here to view this seminar in full screen.

Webinar: Setting priorities for COVID-19 vaccine allocation

21/09/2020

If and when a safe and effective COVID-19 vaccine becomes available, there will not be enough to vaccinate everyone who wants it. Difficult decisions will have to be made about the allocation of available vaccines both between and within countries. What values should guide vaccine allocation in a world where governments face competing obligations to their own people and to the global community, and in societies where COVID-19 and control measures have such disparate outcomes for different people?

 



Click here to view this seminar in full screen.

Webinar: Neurological Associations of COVID-19: Learnings from the current literature and 'mutant' responses to COVID-19

10/09/2020

The COVID-19 pandemic, caused by SARS-CoV-2, is of a scale not seen since the 1918 influenza pandemic. Although the predominant clinical presentation is with respiratory disease, neurological manifestations are being recognised increasingly. In this episode, we will discuss what we can learn from the literature on neurological manifestations of COVID-19 and 'mutant' responses to COVID-19.

 



Click here to view Part 1 in full screen.  Watch Part 2 here.

Webinar: Engagement at a distance - Sharing lessons from experience

10/09/2020

What does it take to develop meaningful and valuable experiences online? What are the important lessons we have all learnt about engagement during the COVID-19 crisis? We hear from engagement practitioners who have run successful projects that did not rely on meeting face-to-face. They share their learning and discuss the challenges and advantages of engagement at a distance. We also learn top-tips on designing and facilitating virtual events and try out some interactive tools that can be used to enhance engagement online, whilst meeting other webinar participants in the process.

 



Click here to view this seminar in full screen.

Lessons from a Zika Network to Covid-19 response and beyond

19/08/2020

This session will present how a consortium which was set-up to respond to one epidemic is leveraging the expertise held by teams within, to respond to another. Under the current pressure of Covid-19, panellists will have the opportunity to illustrate the power and role of ‘research networks’, and how within this framework, teams and skills fostered from one effort have laid the foundation for a stronger response in the face of a subsequent disease outbreak. Leading scientists from the ZikaPLAN consortia will reflect on what can be meaningfully carried forward from lessons with arboviruses, so as to avoid reinventing the wheel.

 

 

 



Epidemics Ethics: Covid: A case for research exceptionalism?

10/08/2020

The current COVID-19 pandemic has reignited calls to amend, adapt and short-cut the research design process. But does the current pandemic and the need for an urgent response necessitate that we rethink our current research models? What can we learn from the discussions that have occurred in and following past outbreaks on appropriate research design, especially the 2014-15 Ebola outbreak? Does there necessarily need to be a trade-off between scientific rigour and speed? What role can ethicists play in supporting the global research community to undertake scientifically and ethically robust research in this current pandemic?

 


 Click here to view this seminar in full screen.

 

Understanding the gendered dimensions of COVID-19

31/07/20

Pandemics, including COVID-19, are not gender neutral. Evidence shows that the current COVID-19 pandemic is differentially affecting men, women, and people of other genders – both in terms of immediate primary effects and more long term secondary effects. This webinar will discuss the gendered dimensions of COVID-19 in three country contexts, drawing on evidence from two gender and COVID projects working across nine contexts.



Click here to view this seminar in full screen. 

Ethicists advising public health authorities: opportunities and challenges

27/07/2020

The COVID-19 pandemic has raised a number of distinctive and profound ethical challenges. It is therefore unsurprising that public health authorities have turned to ethicists for advice when developing and implementing policies and measures in their pandemic response. This has created many opportunities for ethicists to enhance the moral quality of public health decision-making; however, it has also raised a number of challenges, both substantive and procedural. This seminar presents the experiences and perspectives of ethicists who have played key roles in advising public health authorities in four countries during the COVID-19 pandemic.

 



Click here to view this webinar in full screen. 

Neurological disorders associated with COVID-19: The Known and Unknown, and special focus on Alzheimer's dementia

02/07/2020

The COVID-19 pandemic, caused by SARS-CoV-2, is of a scale not seen since the 1918 influenza pandemic. Although the predominant clinical presentation is with respiratory disease, neurological manifestations are being recognised increasingly. In this episode, we will review complications of COVID-19 in patients with Alzheimer’s disease, as well as get some more insights into what’s known and unknow about Neurological Conditions in the Context of COVID-19.



Click here to view this seminar in full screen. 

An Epidemic of Research: publication ethics during a public health emergency

29/06/2020

The urgency and global nature of the COVID-19 pandemic has resulted in health research being undertaken at an unprecedented scale. This has been accompanied by a race to disseminate, share and publish data and findings, which in turn has led to retractions, questionable peer review, and pre-publication peer review via twitter, resulting in confusion amongst researchers, regulators, and the public. What has this meant for credibility of science and trust in the scientific enterprise? What are the real costs here? How can publishing models accommodate our need for urgency, research integrity and trustworthiness when they're needed most?

 



Click here to view this seminar in full screen. 

Beyond ‘good enough’: How to engage communities with COVID-19 research quickly and effectively

15/06/2020

Response to COVID-19 requires rapid research to develop vaccines, treatments and other kinds of urgently needed knowledge. Previous public health emergencies have demonstrated that good community engagement helps move research forward, ensures it is feasible, relevant, and accepted, and that its findings are taken up. But how can it be done quickly, and in the midst of lockdowns? On this webinar we will explore these questions, and hear from the experts how to bring Good Participatory Practices to COVID-19 research.

 



Neurological disorders associated with COVID-19: Guillain-Barré Syndrome Cases and Patients on Immunomodulators

09/06/2020

The COVID-19 pandemic, caused by SARS-CoV-2, is of a scale not seen since the 1918 influenza pandemic. Although the predominant clinical presentation is with respiratory disease, neurological manifestations are being recognised increasingly. After a successful first webinar, we will now review the first few cases of Guillain-Barré syndrome (GBS) following SARS-CoV-2 infection and discuss the management of patients on immunomodulators during the COVID-19 pandemic.

A workshop report is available here.



Click here to view this seminar in full screen. 

Reaching a Global Consensus on What the Research Priorities are now for COVID-19 to Guide Funding

05/06/2020

Several major international research funding organisations are planning further calls to respond to the current COVID-19 pandemic. To ensure their funding decisions will address critical global knowledge gaps. The Global Health Network, the African Academy of Sciences and the UKCDR have conducted a survey to seek the opinion of researchers globally as to the top priorities for COVID-19 research in their country and region (more information here). To complement the survey, join us for an open discussion and help us guide major research funders with your expertise on what COVID-19 research should be prioritised.

A workshop report is available here.



Click here to view this seminar in full screen. 


Digital Technologies and their Ethical Application during the COVID-19 Pandemic

01/06/2020

Digital technologies, including those that utilize artificial intelligence, are increasingly being used to aid COVID-19 surveillance and response efforts. While these digital technologies, such as digital proximity tracking technologies, will undoubtedly play an important role, their use raises important ethical and governance concerns. This webinar will discuss the use of digital technologies, the ethical and human rights implications of their use, and possible ways forward in implementing such technologies in a manner that upholds and promotes key ethical norms.

A workshop report will be available soon.



Click here to view this seminar in full screen. 


COVID-19 Human Challenge Studies: Is it OK for research participants to volunteer to be infected?

18/05/2020

As widespread use of safe and efficacious vaccines for COVID-19 could save many lives and enable governments to ease restrictive control measures, there is an urgent ethical imperative for well-designed and carefully conducted research to develop such vaccines and increase relevant scientific knowledge regarding SARS-CoV-2. Controlled human infection studies, also known as human challenge studies, have been proposed as one means of testing the many vaccine candidates for SARS-CoV-2. While this has attracted considerable attention with wide calls for COVID-19 challenge studies, the research community is divided over their ethical acceptability.

A workshop report will be available soon.



Click here to view this seminar in full screen. 


REMAP-CAP and Why We Need Platform Trials in a Pandemic: An Open Webinar

13/05/2020

The purpose of this webinar is to introduce the concept of adaptive platform trials, introduce REMAP-CAP to new countries, and seek input into what the barriers might be and whether any adaptations might be required for different settings around the world? Platform trials will be discussed more broadly, as they can bring evidence across the whole disease spectrum and so can be considered in primary care settings, district hospitals, and community-level interventions to determine what interventions can work in a variety of situations.

A workshop report is available here.



Click here to view this seminar in full screen. 


COVID-19 Webinar: How are Nurses in Africa Facing the Challenge? 

11/05/2020

This workshop was organized by The Global Health Network in partnership with Global Research Nurses. This aimed establish an open community of practice of Nurses across Africa to support the implementation of research within COVID-19, bringing together regional experts in the field, with input from Nigeria, South Africa, and Zambia. 

 

A workshop report is available here.



Click here to view this seminar in full screen. 


COVID-19 Immunity Passports: Inevitable? Ethical?

04/05/2020

Assuming that recovery from COVID-19 brings a measure of immunity, some have proposed that the detection of antibodies to the SARS-CoV-2 virus could serve as the basis for an ‘immunity passport’ that would enable individuals to travel or to return to work. While health officials and scientists continue to review the evidence on antibody responses to SARS-CoV-2 infection, critical ethical questions related to stigma, health inequities, and the evidential basis for the use of immunity passports must be addressed.

A workshop report will be available soon.



Click here to view this workshop in full screen. 


Taller virtual COVID-19 para países de hablahispana

COVID-19 Virtual Workshop for Spanish-speaking Countries

27/04/2020

This was our first webinar for Spanish-speaking countries, specially focused across Latin America and the Caribbean. This webinar aimed to highlight the current research gaps that need urgent attention in this region and establish an open community of practice to support the implementation of research within COVID-19 for countries across LAC region. It brought together experts in the field from across Brazil, Chile, Colombia, Dominican Republic, El Salvador and Honduras.

 

A workshop report is available here.



Click here to view this workshop in full screen. 


Neurological Disorders Associated with COVID-19

01/05/2020

The COVID-19 pandemic, caused by SARS-CoV-2, is of a scale not seen since the 1918 influenza pandemic. Although the predominant clinical presentation is with respiratory disease, neurological manifestations are being recognised increasingly. This webinar reviewed what’s known about neurological manifestations of SARS CoV-2 and related coronaviruses, consider the disease mechanisms and outline a framework for future investigative studies.

A workshop report is available here.

 

 

Click here to view this workshop in full screen. 

Atelier virtuel COVID-19 pour les pays francophones

Virtual COVID-19 Workshop for French-speaking Countries

24/04/2020

This workshop was organized by The Global Health Network in partnership with the African coaLition for Epidemic Research, Response and Training (ALERRT). This aimed to highlight the current research gaps and establish an open community of practice to support the implementation of research within COVID-19 for Francophone countries across Sub-Saharan Africa, bringing together regional experts in the field, with input from Mali, DRC, Madagascar, Burkina Faso, Cameroon, and South Africa.

A workshop report is available here.

 


 

Click here to view this workshop in full screen. 

How are we Responding to the COVID-19 Open Research Challenge? Experiences from South Asia.

23/04/2020 

Questions around disease surveillance and characterisation as well as challenges related to prevention, diagnostics and management for COVID-19 arise in different regions. This workshop was organised in partnership with the Clinical Research Office, Shaukat Khanum Memorial Cancer Hospital and Research Centre in Pakistan, bringing together experts in the field from across Pakistan, India, Bangladesh and Nepal to understand how South Asian countries are reacting to the outbreak and identifying the research gaps that need urgent attention in these settings.

A workshop report is available here.

 


 

Click here to view this workshop in full screen. 

 

What Impact Could COVID-19 Have on Malaria?

14/04/2020

As the COVID-19 pandemic unfolds, questions arise around malaria, specifically the implications for co-infection, immunology, malaria outcomes and health-care systems. In the first instance, it is important to establish the relevant research questions to address.

The Global Health Network and the Malaria Consortium bring together an expert panel and open a platform to discuss this important concern, share ideas, strategies and potentially set up some research collaborations.

A workshop report is available here.



Click here to view this seminar in full screen. 


Why Should Ethics be Front and Centre to the Response to COVID-19. Is it?

20/04/2020

This is the first online seminar from PHEPREN (Public Health Emergency Preparedness and Response Ethics Network), the newly launched global community of bioethicists, established to provide real-time, trusted, contextual support to communities, policy makers, researchers, and responders in relation to the ethical issues arising out of global health emergencies. 

 

 


 

Click here to view this workshop in full screen. 

 

Como estamos respondendo ao desafio de pesquisa em COVID-19?

How Are We Responding to the Research Challenges in COVID-19?

31/03/2020

Our first Lusophone webinar was organised in partnership with Fiocruz, a health institution (linked to the Brazilian Ministry of Health) playing a major role in the response to COVID-19, alongside a panellist from the Centre for Health Research in Angola sharing her experiences in that setting.

As a result of this workshop, where the scarce access to lusophone training materials and research toolkits was highlighted, a COVID-19 study group for lusophone countries (Comunidade de Países de Língua Portuguesa) is being established to share materials and promote the exchange of challenges and solutions. 

View the workshop report here.



Click here to view this workshop in full screen. 


The COVID-19 Open Workshop for Research Implementation: Session 2 

13/03/2020

As the first workshops in this series, The Global Health Network supported two workshops (same format; different time zones). These had panellists from over six countries (Thailand, Rwanda, Kenya, Mozambique, Brazil, Honduras) and over 600 people registered from across Africa, Asia and Latin America.

The aim was to establish an open community of practice to support the implementation of research during the COVID-19 in varied situations, including fragile health systems.  

View the workshop report here.



Click here to view this workshop in full screen. 


The COVID-19 Open Workshop for Research Implementation: Session 1 

13/03/2020

As the first workshops in this series, The Global Health Network supported two sessions (same format; different time zones). These had panellists from over six countries (Thailand, Rwanda, Kenya, Mozambique, Brazil, Honduras) and over 600 people registered from across Africa, Asia and Latin America.

The aim was to establish an open community of practice to support the implementation of research during the COVID-19 pandemic in varied situations, including fragile health systems.  

View the workshop report here.

 

This is the first of a discussion series on outbreak preparedness and response to encourage sharing of experiences and reflections that further our understanding of how we can best support learning in these contexts. It will include presentations on educational programmes developed in response to disease outbreaks.